ImmunoGen
IMGN
#2137
Rank
C$12.07 B
Marketcap
C$43.24
Share price
0.00%
Change (1 day)
129.09%
Change (1 year)

Market capitalization of ImmunoGen (IMGN)

Last known market cap: C$12.07 Billion

On April 12, 2024 ImmunoGen had a market cap of C$12.07 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunoGen from 2001 to 2024

End of year Market Cap

Year Marketcap Change
2024C$12.51 B18.93%
2023C$10.52 B608.47%
2022C$1.48 B-28.62%
2021C$2.08 B29.98%
2020C$1.60 B59.97%
2019C$1.00 B2.47%
2018C$0.97 B-8.35%
2017C$1.06 B345.32%
2016C$0.23 B-85.39%
2015C$1.63 B168.88%
2014C$0.60 B-54.43%
2013C$1.33 B25.28%
2012C$1.06 B18.55%
2011C$0.90 B42.99%
2010C$0.62 B32.85%
2009C$0.47 B78.9%
2008C$0.26 B49.17%
2007C$0.17 B-27.74%
2006C$0.24 B0.18%
2005C$0.24 B-43.4%
2004C$0.43 B63.02%
2003C$0.26 B28.69%
2002C$0.20 B-80.33%
2001C$1.05 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
C$59.74 B 394.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$239.48 B 1,882.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$1.238 T 10,150.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$145.62 B 1,105.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$672.52 B 5,467.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$202.85 B 1,579.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$345.79 B 2,762.94%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$163.69 B 1,255.29%๐Ÿ‡ซ๐Ÿ‡ท France